Administering immunotherapy when the tumor microenvironment is most susceptible to T cells enhances treatment efficacy in ...

Immune checkpoint inhibitors (ICIs) redefined the therapeutics of non-small cell lung cancer (NSCLC), leading to significant survival benefits and unprecedented durable responses. However, the ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

Introducing a #ventilator-on-a-chip model, a cutting-edge tool designed to study #lungdamage and improve our understanding of ...